09 February 2025 : Clinical Research
Inflammatory Biomarkers from Blood Counts as Prognostic Tools in Metastatic Esophageal Cancer
Yonca Yılmaz Ürün
ABF 1, İsmail Beypınar CDE 2*
DOI: 10.12659/MSM.947202
Med Sci Monit 2025; 31:e947202
Table 1 Demographic, clinical and pathologic findings of the patients.
| Feature | Percentage | Feature | Percentage | Feature | Percentage |
|---|---|---|---|---|---|
| Sex | ECOG | Dist. LN met. | 53.2 | ||
| Male | 41.6 | 0 | 46.9 | ||
| Female | 58.4 | 1 | 41.6 | ||
| 2 | 11.5 | ||||
| HT | 19.5 | Histology | Liver met. | 36.5 | |
| SCC | 81.4 | ||||
| Adeno | 15.9 | ||||
| Small Cell | 2.7 | ||||
| DM | 8 | Grade | Lung met. | 25.6 | |
| 1 | 5.1 | ||||
| 2 | 75.8 | ||||
| 3 | 19.1 | ||||
| CAD | 8 | Obstruction | 38.7 | Bone met. | 9.8 |
| COLD | 5.3 | Localization | Peritoneal met. | 2.8 | |
| Upper | 11.3 | ||||
| Middle | 49.3 | ||||
| Lower | 39.4 | ||||
| Dysphagia | 94.1 | Brain met. | 2.9 | ||
| Weight Loss | 46.9 | ||||
| 1 line response | |||||
| CR | 15 | ||||
| PR | 37.2 | ||||
| SD | 29.2 | ||||
| PD | 18.6 | ||||
| HT – hypertension; DM – diabetes mellitus; CAD – coronary artery disease; COLD – chronic obstructive lung disease; LN – lymph node; Dist – distant; Met – metastasis; CR – complete response; PR – partial response; SD – stabil disease; PD – progressive disease; SCC – squamous cell carcinoma; Adeno – ddenocarcinoma. | |||||